HORIZON KINETICS ASSET MANAGEMENT LLC - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 155 filers reported holding ZIOPHARM ONCOLOGY INC in Q1 2021. The put-call ratio across all filers is 0.76 and the average weighting 0.1%.

Quarter-by-quarter ownership
HORIZON KINETICS ASSET MANAGEMENT LLC ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q3 2023$4,481
-74.2%
34,0000.0%0.00%
Q2 2023$17,340
-19.0%
34,0000.0%0.00%
Q1 2023$21,420
-2.9%
34,0000.0%0.00%
Q4 2022$22,069
-62.0%
34,0000.0%0.00%
-100.0%
Q3 2022$58,000
+38.1%
34,0000.0%0.00%0.0%
Q2 2022$42,000
+90.9%
34,0000.0%0.00%
Q1 2022$22,000
-40.5%
34,0000.0%0.00%
-100.0%
Q4 2021$37,000
-40.3%
34,0000.0%0.00%0.0%
Q3 2021$62,000
-31.1%
34,0000.0%0.00%
-50.0%
Q2 2021$90,000
-26.2%
34,0000.0%0.00%
-33.3%
Q1 2021$122,00034,0000.00%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q1 2021
NameSharesValueWeighting ↓
Third Security, LLC 9,709,607$60,394,0003.07%
MSD Partners, L.P. 3,410,500$21,213,0001.32%
MILLER VALUE PARTNERS, LLC 4,926,456$30,643,0001.24%
Michael & Susan Dell Foundation 66,749$415,0000.33%
ACUTA CAPITAL PARTNERS, LLC 150,000$933,0000.26%
Piermont Capital Management Inc. 85,500$532,0000.15%
A.R.T. Advisors, LLC 411,547$2,559,0000.14%
EQUITEC PROPRIETARY MARKETS, LLC 96,100$598,0000.14%
Vident Investment Advisory, LLC 204,744$1,274,0000.10%
EQUITEC PROPRIETARY MARKETS, LLC 68,800$428,0000.10%
View complete list of ZIOPHARM ONCOLOGY INC shareholders